Who invested in Alentis Therapeutics?
6 investors are on record as having backed Alentis Therapeutics — Developing antibody drugs for cancer and fibrosis, in Biotech, United States. Each row below says whether the round came from the investor's own portfolio page or from the press.
alentis.chAlentis Therapeutics investors
Jeito Capital LLCFinances and accelerates ground-breaking medical innovation with a patient benefit driven…growth$181.4MNov 2024press
Avego Bioscience CapitalBacks companies developing and commercializing innovative healthcare products and…growth$181.4MJan 2024press
4 more investors on record for Alentis Therapeutics.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
The funds that backed Alentis Therapeutics are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.